Merion Book Value per Share
The Book Value per Share of Merion (EWLU) as of Oct 30, 2026 is -0.02 USD.
Get this data via API
Financial Data API
Book Value per Share
-0.02USD
YoY
602.21%
Last updated:
Book Value per Share of Merion is 2021 -0.02 USD. Book Value per Share of Merion was 2020 -0.00 USD. It decreases by 602.21% lower compared to the previous year.
The Merion Book Value per Share history
3 Years
10 Years
25 Years
Max
Book Value per Share
Date
Book Value per Share
Jan 1, 2014
-0.12 USD
Jan 1, 2015
-0.22 USD
Jan 1, 2016
-0.23 USD
Jan 1, 2017
-0.11 USD
Jan 1, 2018
-0.10 USD
Jan 1, 2019
-0.09 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.02 USD
| YEAR | Book Value per Share | YoY |
|---|---|---|
| -0.02USD | +602.21% | |
| -0.00USD | -96.83% | |
| -0.09USD | -16.98% | |
| -0.10USD | -10.45% | |
| -0.11USD | -49.75% | |
| -0.23USD | +5.46% | |
| -0.22USD | +77.78% | |
| -0.12USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Merion Stock analysis
What does Merion do? Merion, Inc. generates revenue by selling its own line of seven nutritional supplements and seven skin-care products through its website dailynu.com. The company's nutritional supplements, including Dibeier Granules & Oral, Longevity, US-Liver Gold, Cell Power, OPC Spa, Heart Power, and O2 Cell Power, are formulated using a micro molecular nutrition process. Its skin-care products, such as anti-aging cream, facial cream, facial serum, body lotion, sun protection, facial toner, and facial cleanser, focus on restoring epidermal calcium. The firm also sells third-party health and nutrition products that are already available through other vendors.
The company's primary customers are individuals seeking health and nutritional supplements and personal care products, purchasing directly through dailynu.com. Merion does not manufacture its own skin-care products but distributes third-party brands that are already sold by other vendors. The firm's revenue streams include direct sales of its proprietary supplement line and the third-party products it resells.
Merion's business model relies on e-commerce sales via its website, with no physical retail presence. The company's product portfolio is divided into two main segments: its own micro molecular nutrition supplements and third-party health and nutrition products. The skin-care segment focuses on products that restore epidermal calcium, while the nutritional segment features seven proprietary supplements made using its unique formula. Merion is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Merion stock
Book Value per Share of Merion is -0.02 USD in 2021.
On Eulerpool you can find the complete historical development of Book Value per Share Merion since 2006 – with annual values, charts, and detailed analysis.
Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Merion
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Merion
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth